Assignee
HUABO BIOPHARM SHANGHAI CO LTD
CN·3 granted patents·1 pending application·0 citations·filing 2018–2021
Top patents by PatentIndex Score
4 records- 0154US12269885B2Anti-PD-L1/VEGF bifunctional antibody and use thereofHUABO BIOPHARM SHANGHAI CO LTD·Filed 2020·Granted Apr 8, 2025·0 cites·12 claims
- 0252US12338284B2Binder against programmed death-ligand and application thereofHUABO BIOPHARM SHANGHAI CO LTD·Filed 2020·Granted Jun 24, 2025·0 cites·10 claims
- 0345US2023183345A1Anti-tigit antibody and preparation method and application thereofHUABO BIOPHARM SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 0443US10981983B2Antibody targeting interleukin 17A and preparation method and application thereofHUABO BIOPHARM SHANGHAI CO LTD·Filed 2018·Granted Apr 20, 2021·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when HUABO BIOPHARM SHANGHAI CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →